Literature DB >> 32311011

CpG methylation in cell-free Epstein-Barr virus DNA in patients with EBV-Hodgkin lymphoma.

Meir Shamay1,2, Jennifer A Kanakry1,3, John S W Low4, Netanel A Horowitz5, Guy Journo2, Anuj Ahuja2, Yonatan Eran2, Elinor Barzilai5, Eldad J Dann5,6, Jennifer Stone1, Wan Lu Woo4, Wen-Son Hsieh4, Rena R Xian1,7, Richard F Ambinder1.   

Abstract

Epstein-Barr virus (EBV) is associated with a variety of tumors and nonmalignant conditions. Latent EBV genomes in cells, including tumor cells, are often CpG methylated, whereas virion DNA is not CpG methylated. We demonstrate that methyl CpG binding magnetic beads can be used to fractionate among sources of EBV DNA (DNA extracted from laboratory-purified virions vs DNA extracted from latently infected cell lines). We then applied the technique to plasma specimens and showed that this technique can distinguish EBV DNA from patients with EBV-associated tumors (nasopharyngeal carcinoma, Hodgkin lymphoma) and viral DNA from patients without EBV-associated tumors, including immunocompromised patients and patients with EBV(-) Hodgkin lymphoma.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32311011      PMCID: PMC7189298          DOI: 10.1182/bloodadvances.2020001511

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  19 in total

1.  Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B cell lymphoproliferative disease. Application of PCR-based analysis.

Authors:  Q Tao; L J Swinnen; J Yang; G Srivastava; K D Robertson; R F Ambinder
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

2.  Plasma Epstein-Barr Virus DNA for Screening.

Authors:  Richard F Ambinder
Journal:  N Engl J Med       Date:  2017-08-10       Impact factor: 91.245

Review 3.  Role of epigenetics in EBV regulation and pathogenesis.

Authors:  Hans Helmut Niller; Zsófia Tarnai; Gábor Decsi; Adám Zsedényi; Ferenc Bánáti; Janos Minarovits
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

4.  Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response.

Authors:  J Yang; Q Tao; I W Flinn; P G Murray; L E Post; H Ma; S Piantadosi; M A Caligiuri; R F Ambinder
Journal:  Blood       Date:  2000-12-15       Impact factor: 22.113

5.  Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma.

Authors:  Margaret L Gulley; Sally L Glaser; Fiona E Craig; Michael Borowitz; Risa B Mann; Sarah J Shema; Richard F Ambinder
Journal:  Am J Clin Pathol       Date:  2002-02       Impact factor: 2.493

6.  Analysis of Plasma Epstein-Barr Virus DNA to Screen for Nasopharyngeal Cancer.

Authors:  K C Allen Chan; John K S Woo; Ann King; Benny C Y Zee; W K Jacky Lam; Stephen L Chan; Sam W I Chu; Constance Mak; Irene O L Tse; Samantha Y M Leung; Gloria Chan; Edwin P Hui; Brigette B Y Ma; Rossa W K Chiu; Sing-Fai Leung; Andrew C van Hasselt; Anthony T C Chan; Y M Dennis Lo
Journal:  N Engl J Med       Date:  2017-08-10       Impact factor: 91.245

7.  Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.

Authors:  Rui Guo; Ling-Long Tang; Yan-Ping Mao; Xiao-Jing Du; Lei Chen; Zi-Chen Zhang; Li-Zhi Liu; Li Tian; Xiao-Tong Luo; Yu-Bin Xie; Jian Ren; Ying Sun; Jun Ma
Journal:  Cancer       Date:  2018-10-23       Impact factor: 6.860

8.  The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases.

Authors:  Jennifer A Kanakry; Aparna M Hegde; Christine M Durand; Allan B Massie; Amy E Greer; Richard F Ambinder; Alexandra Valsamakis
Journal:  Blood       Date:  2016-01-07       Impact factor: 22.113

9.  Prevalence and relevance of EBV latency in nasopharyngeal carcinoma in Israel.

Authors:  G Bar-Sela; A Kuten; I Minkov; E Gov-Ari; O Ben-Izhak
Journal:  J Clin Pathol       Date:  2004-03       Impact factor: 3.411

10.  Detection and localization of surgically resectable cancers with a multi-analyte blood test.

Authors:  Joshua D Cohen; Lu Li; Yuxuan Wang; Christopher Thoburn; Bahman Afsari; Ludmila Danilova; Christopher Douville; Ammar A Javed; Fay Wong; Austin Mattox; Ralph H Hruban; Christopher L Wolfgang; Michael G Goggins; Marco Dal Molin; Tian-Li Wang; Richard Roden; Alison P Klein; Janine Ptak; Lisa Dobbyn; Joy Schaefer; Natalie Silliman; Maria Popoli; Joshua T Vogelstein; James D Browne; Robert E Schoen; Randall E Brand; Jeanne Tie; Peter Gibbs; Hui-Li Wong; Aaron S Mansfield; Jin Jen; Samir M Hanash; Massimo Falconi; Peter J Allen; Shibin Zhou; Chetan Bettegowda; Luis A Diaz; Cristian Tomasetti; Kenneth W Kinzler; Bert Vogelstein; Anne Marie Lennon; Nickolas Papadopoulos
Journal:  Science       Date:  2018-01-18       Impact factor: 47.728

View more
  3 in total

Review 1.  Epigenetic control of the Epstein-Barr lifecycle.

Authors:  Rui Guo; Benjamin E Gewurz
Journal:  Curr Opin Virol       Date:  2021-12-08       Impact factor: 7.121

2.  Feasibility of Cell-Free DNA Collection and Clonal Immunoglobulin Sequencing in South African Patients With HIV-Associated Lymphoma.

Authors:  Samantha L Vogt; Moosa Patel; Atul Lakha; Vinitha Philip; Tanvier Omar; Philippa Ashmore; Sugeshnee Pather; Lisa M Haley; Gang Zheng; Jennifer Stone; Elizabeth Mayne; Wendy Stevens; Nina Wagner-Johnston; Christopher D Gocke; Neil A Martinson; Richard F Ambinder; Rena R Xian
Journal:  JCO Glob Oncol       Date:  2021-04

3.  Plasma EBV DNA: A Promising Diagnostic Marker for Endemic Burkitt Lymphoma.

Authors:  Rena R Xian; Tobias Kinyera; Isaac Otim; Joshua N Sampson; Hadijah Nabalende; Ismail D Legason; Jennifer Stone; Martin D Ogwang; Steven J Reynolds; Patrick Kerchan; Kishor Bhatia; James J Goedert; Sam M Mbulaiteye; Richard F Ambinder
Journal:  Front Oncol       Date:  2021-12-14       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.